The FDA has issued a CRL to Lexicon regarding the NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for T1D and CKD.

Underweight pregnancy was associated with lower risk for postpartum hemorrhage but higher risks for adverse neonatal outcomes.

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

Results from the VENTURE trial showed significant reductions in weight and hunger among younger patients treated with setmelanotide.

For elderly patients with atrial fibrillation, regular coffee consumption is associated with higher cognitive performance.

HealthDay News — The risk for breast cancer is increased with weight gain after age 35 years, according to a research letter recently published in Cancer Biology & Medicine.

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

CGM prescription rates were low at federally qualified health centers, especially among patients without insurance and non-White patients.